SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?


To: maverick61 who wrote (49592)3/21/2001 6:53:57 PM
From: Baton  Read Replies (1) | Respond to of 57584
 
Maverick: Ya, I watch the BBH. Watched it bounce upward off $141 4-5 times in the last 6 weeks. Wouldn't you know it though when I finally bought it at at $139 it continued on down to where it is now at ..what $105? Thank goodness for stop loss as I stopped out at $135. I would like to own it for a biotech run, but falling knives and all - I just don't know where to buy it. If it gets to the mid 90's, I'll probably buy some, just close my eyes and tuck it away.
I feel biotech will come back with a vengence, and just might be our next market leader. It has been crushed.
Baton



To: maverick61 who wrote (49592)3/22/2001 8:17:53 AM
From: bosquedog  Read Replies (2) | Respond to of 57584
 
Faber reported on Squawk Box that Goldman thought the big cap first tier biotechs would rebound first.

Course, that is a thought that would seem valid on almost any sector when it rebounds.<G>